Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (GOSS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $59.9M; returns 1 day +1.5%, 1 week +9.5%, 1 year -94.3%.

Gossamer Bio Inc is a late-stage clinical biopharmaceutical company primarily focused on the development and commercialization of seralutinib (GB002), a novel inhaled PDGFR, CSF1R, and c-KIT inhibitor.

Groups GOSS belongs to

• Biotechnology
• Biopharmaceutical
• Recent Reverse Splits
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Healthcare
• Life Sciences
• Unmet Medical Needs

GOSS financial model: income statement, cash flow and balance sheet